Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

3.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.5K
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

7.0K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical 5-fluorouracil versus photodynamic therapy: Differential impact on epidermal clonal mutations in early UV-induced skin carcinogenesis.

The Journal of investigative dermatology·2026
Same author

Deep Learning-Based Structure Modeling of the <i>Treponema pallidum</i> Proteome: Insights into Pathogenesis and Syphilis Vaccine Development.

bioRxiv : the preprint server for biology·2026
Same author

Improving Access to Community Occupations via Rideshare: A Pilot Study With Autistic Adults.

The American journal of occupational therapy : official publication of the American Occupational Therapy Association·2026
Same author

Diameter, height, and volume as macroscopic predictors of photocarcinogenesis in UV-induced SKH1 papules.

Journal of photochemistry and photobiology. B, Biology·2026
Same author

Acute UV response of early erythema and late edema in SKH1 mice.

Journal of photochemistry and photobiology. B, Biology·2026
Same author

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025

Related Experiment Video

Updated: Mar 12, 2026

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures
09:06

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures

Published on: December 13, 2019

9.6K

The Efflux Transporter ABCG2 Maintains Prostate Stem Cells.

Neha G Sabnis1, Austin Miller2, Mark A Titus3

  • 1Department of Pharmacology & Therapeutics, Roswell Park Cancer Institute, Buffalo, New York.

Molecular Cancer Research : MCR
|November 19, 2016
PubMed
Summary

Targeting ABCG2 in prostate stem cells (PSCs) can reverse androgen deprivation therapy resistance. Inhibiting ABCG2 promotes androgen receptor activity and differentiation, making cancer cells more sensitive to treatment.

More Related Videos

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.7K
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

9.6K

Related Experiment Videos

Last Updated: Mar 12, 2026

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures
09:06

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures

Published on: December 13, 2019

9.6K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.7K
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
10:38

Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture

Published on: November 22, 2019

9.6K

Area of Science:

  • Prostate cancer research
  • Stem cell biology
  • Cancer therapeutics

Background:

  • Prostate stem cells (PSCs) exhibit resistance to androgen deprivation therapy (ADT), a common prostate cancer treatment.
  • This resistance is potentially linked to low androgen receptor (AR) expression and the role of ABCG2 transporters in regulating intracellular androgens.
  • Understanding PSC maintenance mechanisms is crucial for developing effective differentiation therapies for castration-resistant prostate cancer (CRPC).

Purpose of the Study:

  • To investigate the role of ABCG2-mediated androgen efflux in maintaining the undifferentiated state of prostate stem cells.
  • To explore the therapeutic potential of inhibiting ABCG2 for differentiation therapy in prostate cancer.

Main Methods:

  • Utilized HPr-1-AR (nontumorigenic) and CWR-R1 (tumorigenic) prostate cell lines.
  • Administered Ko143, an ABCG2 inhibitor, to block androgen efflux.
  • Assessed AR expression, AR-regulated gene expression, cell growth, and tumor development in mouse models.

Main Results:

  • Inhibiting ABCG2 with Ko143 increased intracellular androgen levels and nuclear AR expression.
  • This led to increased AR-regulated gene expression, delayed cell growth, and enhanced luminal differentiation.
  • Ko143 treatment reduced tumor growth rates and increased the percentage of differentiated CK8+/AR+ luminal cells in vivo.

Conclusions:

  • ABCG2-mediated androgen efflux is essential for maintaining prostate stem cells in an undifferentiated state.
  • Targeting ABCG2 forces PSCs to differentiate into an ADT-sensitive luminal phenotype via AR modulation.
  • Inhibiting ABCG2 represents a promising strategy for differentiation therapy in prostate cancer, particularly CRPC.